Renewing the committee to study non-pharmacological treatment options for patients with chronic pain.
Impact
If passed, HB1712 would extend the committee's mandate to analyze and design a pilot program aimed at evaluating the efficacy of non-pharmacological treatment approaches. The proposed program is expected to involve collaboration with state health programs such as New Hampshire's Medicaid and its self-funded health insurance initiative. Additionally, the bill fosters awareness and accessibility of non-pharmacological options through educational initiatives for primary care providers, aiming to enhance collaborative care for patients experiencing chronic pain.
Summary
House Bill 1712 aims to renew the committee that studies non-pharmacological treatment options for patients with chronic pain. This bill emphasizes a patient-centric approach to managing chronic pain, encouraging the exploration of integrated care models. The intent is to develop a pilot program that could potentially transform how chronic pain is treated, focusing on therapies that do not involve pharmaceuticals. The committee's findings from the previous year indicated a credible setup for building a pilot program based on a patient-friendly framework that aligns with existing healthcare provider networks.
Contention
While the bill has potential benefits, there could be points of contention regarding the funding and implementation of the proposed pilot program. Stakeholders may bring up the need for adequate financial resources to support the innovative payment methods the committee is expected to explore. Furthermore, there may be debates on how effectively the committee can ensure the program meets its cost management goals while also providing quality outcomes for patients. The balance between affordability for patients and the comprehensive approach to chronic pain management will likely be a crucial topic of discussion.
An Act Concerning The Adequate Prescription Of Pain Medication For Cancer Patients, Palliative And Nursing Home Patients And Patients Experiencing Chronic Intractable Pain.